A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands
International Journal of Epidemiology · 2023
DOI: 10.1093/ije/dyad124 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, 2023. Verfasst von Andrea Gini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Surveillance Branch, International Agency for Research on Cancer (IARC), Lyon, France. Hauptthemen laut MEDLINE: Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: World Health Organization, Children with Cancer UK.
Abstract (Originalsprache)
Background
Estimating the number of childhood cancer survivors is crucial for cancer control, including clinical guidelines. To compare estimates across countries despite data sharing restrictions, we propose a new method of computing limited-duration prevalence of childhood cancer survivors (POCCS) using aggregated data.
Methods
We developed a Markov model that simulates, for each calendar year and birth cohort in a population, the proportion of individuals in the following health states: healthy, newly diagnosed with cancer, surviving with cancer, and deceased. Transitions between health states were informed using annual sex- and age-specific incidence rates, conditional 1-year net survival probabilities from the Netherlands Cancer Registry (1989–2011), and annual mortality probability by sex and age group for The Netherlands from the Human Mortality Database. Applying a Markov model, we computed 20-year prevalence of childhood cancer survivors. The resulting POCCS estimates, stratified by sex, were compared with SEER*Stat estimates derived from individual cancer records from the same registry.
Results
In 2011, POCCS predicted 654 males [95% confidence interval (95% CI): 637–672] and 539 females (95% CI: 523–555) per million persons living in The Netherlands after childhood cancer diagnosed within the previous 20 years. Using SEER*Stat, the 20-year prevalence was 665 males (95% CI: 647–683) and 544 females (95% CI: 529–560) per million persons on 1 July 2011.
Conclusions
Using the POCCS model and aggregated cancer data, our estimates of childhood cancer survivors limited-duration prevalence were consistent with those computed by a standard method requiring individual cancer records. The POCCS method provides relevant information for planning follow-up and care for childhood cancer survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Surveillance Branch, International Agency for Research on Cancer (IARC), Lyon, France.
- Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
- Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Australia.
- National Cancer Registration and Analysis Service, NHS Digital, Didcot, UK.
ORCID-Profile: Andrea Gini
Förderung
- World Health Organization
- Children with Cancer UK
Zitieren
APA
Gini, A., Colombet, M., de Paula Silva, N., Visser, O., Youlden, D., Soerjomataram, I., Stiller, C. A., Steliarova-Foucher, E., & CRICCS Consortium (2023). A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyad124
Vancouver
Gini A, Colombet M, de Paula Silva N, Visser O, Youlden D, Soerjomataram I, et al. A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands. International Journal of Epidemiology. 2023. doi:10.1093/ije/dyad124
BibTeX
@article{Gini2023,
author = {Gini, Andrea and Colombet, Murielle and de Paula Silva, Neimar and Visser, Otto and Youlden, Danny and Soerjomataram, Isabelle and Stiller, Charles A and Steliarova-Foucher, Eva and CRICCS Consortium, CRICCS Consortium},
title = {A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands},
journal = {International Journal of Epidemiology},
year = {2023},
doi = {10.1093/ije/dyad124}
}
EUVIMED